U.S. Other Utilities Stock News

NYSE:M
NYSE:MMultiline Retail

A Look At Macy’s (M) Valuation As 150 Store Closures Reshape Its Bold New Chapter Plan

Why the Pittsburgh Mills closure matters for Macy's stock Macy's (M) decision to close 150 stores in 2026, including the Pittsburgh Mills location, puts its Bold New Chapter restructuring at center stage for anyone tracking the stock. The plan focuses on shutting underproductive sites and redirecting capital to stronger stores and digital channels. It comes against a backdrop of flat same store sales and earnings per share declining 20.7% annually over three years. See our latest analysis for...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Is It Too Late To Consider AST SpaceMobile (ASTS) After Its 286% One-Year Surge?

If you are wondering whether AST SpaceMobile's current share price reflects its true potential, the starting point is to look closely at what the market is paying for each dollar of its business. The stock last closed at US$88.57, after a 4.3% decline over the past week, a 2.6% gain over the past month, and returns of 6.1% year to date and 286.4% over the past year. Recent coverage has focused on AST SpaceMobile's efforts to build a space based cellular broadband network and its progress in...
NYSE:FTV
NYSE:FTVMachinery

How Insider Selling and Aging Profit Engines At Fortive (FTV) Have Changed Its Investment Story

In recent days, Fortive has been in focus as investors reassess the company’s aging profit drivers, flat earnings per share over the past five years, and weaker returns on capital amid ongoing end‑market pressures. An interesting angle is how these operational challenges intersect with recent concerns that Fortive’s shares may be trading above intrinsic value while insiders have sold US$400,000 of stock without corresponding purchases. With investor attention on insider selling and business...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

A Look At Akamai Technologies (AKAM) Valuation After Sharp Share Price Declines And Rising Capex Concerns

Akamai Technologies (AKAM) is back in focus after a sharp drop in its share price, as investors weigh higher capital spending, near term margin pressure, insider selling, and sector rotation toward AI focused platforms. See our latest analysis for Akamai Technologies. The recent 6.4% one day share price decline and 22% 7 day share price return, combined with earlier drops linked to higher capital spending and sector rotation, contrast with a 1 year total shareholder return of 19.2%,...
NYSE:LVS
NYSE:LVSHospitality

Is It Time To Reassess Las Vegas Sands (LVS) After A 73.5% One Year Gain?

If you are wondering whether Las Vegas Sands at around US$55.52 is attractively priced or already reflects most of its prospects, a good starting point is to look closely at what the current valuation is really telling you. The stock has returned 2.8% over the last 7 days and 3.4% over the last 30 days, while year to date it is down 14.9% and up 73.5% over the last year. Together, these figures present a mixed picture of momentum and shifting sentiment. Recent coverage has focused on Las...
NasdaqGS:GIII
NasdaqGS:GIIILuxury

A Look At G-III Apparel Group (GIII) Valuation After Its Latest Earnings Beat And Revenue Growth

G-III Apparel Group (GIII) is back in focus after its latest quarterly earnings report, in which the company beat earnings per share expectations, met revenue projections, and reported higher revenue than the prior-year quarter. See our latest analysis for G-III Apparel Group. The latest report appears to have given the share price some short term momentum, with a 7 day share price return of 4.69% and a 30 day gain of 11.68%. The 1 year total shareholder return of 22.48% and 3 year total...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

Nano Nuclear Energy Explores Argentina Fuel Deal As Shares Trail Target

Nano Nuclear Energy (NasdaqCM:NNE) has proposed a joint project with Argentina's state-run Dioxitek to develop a uranium hexafluoride production facility. The plan represents Nano Nuclear's first formal project step outside the U.S. and extends its involvement into the nuclear fuel conversion segment. The proposal follows an earlier memorandum between the two parties and moves the relationship toward potential commercial terms, pending Argentinian review. Nano Nuclear Energy has mainly been...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

Navy ISR Win and New Leaders Might Change The Case For Investing In AeroVironment (AVAV)

AeroVironment recently appointed Sean T. Woodward as Executive Vice President and Chief Financial Officer, effective May 1, 2026, and earlier this month named Dr. Robert Smith as Executive Vice President and Chief Operating Officer to oversee its Autonomous Systems and Space, Cyber and Directed Energy units. Alongside these leadership changes, AeroVironment’s selection by the U.S. Navy for ISR services using its JUMP 20-X UAS underscores the company’s role in evolving autonomous defense...
NYSE:DHR
NYSE:DHRLife Sciences

Assessing Danaher (DHR) Valuation After New Access MeMed BV Diagnostic Approval

Access MeMed BV approval puts Danaher’s diagnostics in focus Beckman Coulter Diagnostics, part of Danaher (DHR), has received CE 2797 mark approval under the IVDR for its Access MeMed BV assay, a rapid bacterial versus viral infection test delivering results in about 20 minutes. See our latest analysis for Danaher. Despite the positive Diagnostics news, Danaher’s share price has had mixed momentum, with a 6.0% 1 month share price return and a 16.5% 3 month decline, while the 1 year total...
NYSE:BEN
NYSE:BENCapital Markets

Franklin Resources Expands Crypto And Private Credit As Shares Screen Undervalued

Franklin Resources (NYSE:BEN) is acquiring 250 Digital to expand its actively managed institutional crypto strategies. The company is also acquiring Apera to grow its European private credit platform and broaden its alternatives offering. These transactions mark a further push into digital assets and private credit beyond previously discussed product launches and leadership moves. For readers tracking NYSE:BEN, these deals come with the shares recently trading around $26.43 and returns of...
NYSE:CVNA
NYSE:CVNASpecialty Retail

Carvana Insurance Milestone Raises Questions On Growth, Economics And Valuation

Carvana (NYSE:CVNA) and Root report more than 200,000 embedded Carvana Insurance policies sold through their exclusive digital partnership. The milestone reflects traction for fully online auto buying and insurance bundling within a single transaction flow. The collaboration focuses on integrating Root's insurance offering directly into Carvana's digital car retail experience. For readers following NYSE:CVNA, this insurance milestone sits at the intersection of online auto retail and...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Adobe Tesco AI Deal Highlights Retail Opportunity And Valuation Gap

Adobe (NasdaqGS:ADBE) has partnered with Tesco, the UK's largest food retailer, to expand the use of AI in personalized marketing. The collaboration will combine Adobe's AI and engineering capabilities with Tesco's Clubcard data to refine customer targeting and engagement. This agreement marks an extension of Adobe's AI platform into large scale retail customer data and marketing use cases. Adobe, with a current share price of $235.72, has seen negative returns over multiple periods,...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Platforms (META) Is Up 8.2% After Expanding AI Deals And Rolling Out Muse Spark Integration

In recent weeks, Meta Platforms has rolled out its Muse Spark AI model across its apps, while expanding long-term AI infrastructure partnerships such as a US$21.00 billion CoreWeave deal and a multi-year Broadcom collaboration to support its in-house MTIA accelerator chips. At the same time, eMarketer now projects Meta to overtake Google in global digital ad revenue in 2026, underscoring how AI-driven automation and personalization are reshaping Meta’s core advertising franchise and its role...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

Strategy Capital Structure Shifts As STRC Activity And Bitcoin Bets Grow

Strategy Inc. (NasdaqGS:MSTR) is seeing a surge in trading activity in its STRC preferred stock, signaling growing investor focus on this part of its capital structure. The company continues to use preferred equity funding to support Bitcoin acquisitions, shifting a greater share of claims ahead of common shareholders. These changes in trading volume and financing mix are reshaping shareholder risk, liquidity considerations, and the role of preferred holders in the overall capital...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

A Look At Phathom Pharmaceuticals (PHAT) Valuation After Recent Stock Momentum Shift

Stock move puts Phathom Pharmaceuticals in focus Recent trading in Phathom Pharmaceuticals (PHAT) has drawn fresh attention to the gastrointestinal drug developer, with investors weighing its current market value against the ongoing commercialization of VOQUEZNA therapies in the United States. See our latest analysis for Phathom Pharmaceuticals. At a share price of $12.67, recent trading has come after a 22.18% 1 month share price return but follows a 19.35% decline year to date and a 165.62%...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

BioNTech (BNTX) Is Up 9.8% After Strong Phase 2 HER2 ADC Data - Has The Bull Case Changed?

Earlier in April 2026, BioNTech and Duality Biologics reported positive primary Phase 2 data for their HER2-targeted antibody-drug conjugate trastuzumab pamirtecan in previously treated, advanced endometrial cancer, showing clinically meaningful response rates, progression-free survival of around eight months, and a manageable safety profile across all HER2 expression levels. Because the drug already holds FDA Fast Track and Breakthrough Therapy designations and is backed by ongoing Phase 3...
NasdaqGM:STAA
NasdaqGM:STAAMedical Equipment

STAAR Surgical (STAA) Is Up 15.8% After Q1 Revenue More Than Doubles - Has The Bull Case Changed?

STAAR Surgical Company reported preliminary net sales of over US$90,000,000 for the first quarter ended April 3, 2026, compared with US$42,600,000 a year earlier. This sharp year-on-year increase in quarterly revenue highlights a significant step-change in the company’s recent commercial performance and operating momentum. We’ll now examine how this sharp year-on-year revenue increase could reshape STAAR Surgical’s investment narrative and future business expectations. We've uncovered the 12...
NYSE:TSN
NYSE:TSNFood

Tyson Foods (TSN) Valuation In Focus After Plant Closures And Profitability Pressures

Plant closures put Tyson Foods (TSN) cost actions and demand pressures in focus Tyson Foods (TSN) has drawn fresh attention after deciding to shut its Hillshire Brands plant in Rome, Georgia, as part of a broader series of production closures tied to softer meat demand and higher prices. See our latest analysis for Tyson Foods. Shares now trade at US$64.96, with a 30 day share price return of 7.69% and a 1 year total shareholder return of 10.28%. This suggests momentum has been building even...
NYSE:HPE
NYSE:HPETech

A Look At Hewlett Packard Enterprise (HPE) Valuation After Recent Share Price Momentum

Hewlett Packard Enterprise (HPE) has drawn fresh attention after recent share price moves, with the stock showing a roughly 13% gain over the past month and about 11% over the past 3 months. See our latest analysis for Hewlett Packard Enterprise. Set against a 1 year total shareholder return of 67.14% and a 5 year total shareholder return of 79.79%, the recent 13.39% 30 day share price return suggests momentum has been building despite a softer 1 day move. If HPE’s recent move has you...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Is It Time To Reassess Coupang (CPNG) After Its Recent Share Price Rebound?

Wondering if Coupang at around US$20.72 is a bargain or just fairly priced? This article walks through what that number might really mean for you. The stock has returned 8.0% over the last 7 days and 12.3% over the last 30 days, while year to date it is at an 11.3% loss and the 1 year return sits at a 3.5% loss, compared with a 30.6% gain over 3 years and a 51.4% loss over 5 years. Recent headlines around Coupang have focused on its role as a major Korea based e commerce platform and how its...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

A Look At Enphase Energy (ENPH) Valuation As U.S. Microinverter Shipments Expand To Meet Policy Trends

Enphase Energy (ENPH) has put its commercial microinverter push in the spotlight by expanding shipments of its IQ9N-3P and IQ8P-3P units from U.S. facilities to meet installer demand and evolving regulation. See our latest analysis for Enphase Energy. The recent expansion of U.S.-made commercial microinverters comes after a period of weaker share price returns, with a 30-day share price return showing a 27.39% decline and a 1-year total shareholder return reflecting a 39.70% loss, which...
NYSE:APAM
NYSE:APAMCapital Markets

A Look At Artisan Partners Asset Management (APAM) Valuation After Recent Share Price Gains

Recent Performance Snapshot Artisan Partners Asset Management (APAM) has recently drawn attention after a 2.6% move in the latest session, extending its gains over the past week and month while remaining lower across the past 3 months. See our latest analysis for Artisan Partners Asset Management. That recent 1-day share price return of 2.57% and 7-day share price return of 6.59% comes after a weaker patch. The 90-day share price return shows a 12.40% decline, while the 1-year total...
NYSE:LAZ
NYSE:LAZCapital Markets

A Look At Lazard (LAZ) Valuation After New AUM Update And Shifting Analyst Sentiment

Lazard (LAZ) has drawn fresh attention after reporting preliminary assets under management of about US$259.2b as of March 31, 2026, alongside market and FX depreciation and modest net inflows. See our latest analysis for Lazard. The recent AUM update has arrived alongside a sharp short term rebound, with a 7 day share price return of 21.44% and 1 year total shareholder return of 45.61%. However, the 90 day share price return remains slightly negative, which suggests that momentum has only...
NYSE:A
NYSE:ALife Sciences

Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch

Agilent Technologies (A) is back in focus after two contrasting developments: the Supreme Court left rulings invalidating its CRISPR related patents in place, and the company introduced its new BioTek Cytation 9 cell imaging multimode reader. See our latest analysis for Agilent Technologies. At a share price of $120.39, investors have seen a 7.96% 1 month share price return and a 5.72% 7 day gain. However, the 90 day share price return of 17.50% and year to date share price return of 12.73%...